These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26292865)

  • 21. Re: Overactive bladder: a better understanding of pathophysiology, diagnosis and management. A. J. Wein and R. R. Rackley J Urol, suppl., 2006; 175: S5-S10.
    Löfgren OE
    J Urol; 2007 Oct; 178(4 Pt 1):1553; author reply 1553. PubMed ID: 17707052
    [No Abstract]   [Full Text] [Related]  

  • 22. [Guidelines for the surgical treatment of female urinary stress incontinence in women using the suburethral sling].
    Delorme E; Hermieu JF;
    Prog Urol; 2010 Feb; 20 Suppl 2():S132-42. PubMed ID: 20403564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing urinary incontinence: what works?
    Giarenis I; Cardozo L
    Climacteric; 2014 Dec; 17 Suppl 2():26-33. PubMed ID: 25196507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [TVT and concomitant intra-detrusor botox injection for women with mixed urinary incontinence: Is it a good idea?].
    Deffieux X
    Prog Urol; 2021 Mar; 31(4):184-185. PubMed ID: 33714425
    [No Abstract]   [Full Text] [Related]  

  • 25. Urodynamic assessment of children treated with botulinum toxin A injections for urge incontinence: a pilot study.
    Lahdes-Vasama TT; Anttila A; Wahl E; Taskinen S
    Scand J Urol Nephrol; 2011 Dec; 45(6):397-400. PubMed ID: 21740110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing Nonsurgical Treatments of Overactive Bladder in the United States.
    Brucker BM; Lee RK; Newman DK
    Urology; 2020 Nov; 145():52-59. PubMed ID: 32598892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing therapy and management of neurogenic bladder.
    Ginsberg D
    Am J Manag Care; 2013; 19(10 Suppl):s197-204. PubMed ID: 24495241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Craniofacial hyperhidrosis in post-menopausal women.
    Alsharqi A; Wilson NJ
    Australas J Dermatol; 2012 May; 53(2):158-9. PubMed ID: 22571572
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term functional results after unilateral mid-urethral sling transection for voiding dysfunction.
    Baekelandt F; Van Oyen P; Ghysel C; Van der Aa F; Ampe J
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():89-93. PubMed ID: 27833061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urgency Incontinence before and after Revision of a Synthetic Mid Urethral Sling.
    Crescenze IM; Abraham N; Li J; Goldman HB; Vasavada S
    J Urol; 2016 Aug; 196(2):478-83. PubMed ID: 26820550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of sialorrhoea in patients with Parkinson's disease: best current evidence.
    Molloy L
    Curr Opin Neurol; 2007 Aug; 20(4):493-8. PubMed ID: 17620887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis.
    Lee JK; Dwyer PL; Rosamilia A; Lim YN; Polyakov A; Stav K
    BJOG; 2011 Jun; 118(7):798-805. PubMed ID: 21392244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacologic management of idiopathic overactive bladder in primary care.
    Ellsworth PI
    J Fam Pract; 2014 Feb; 63(2 Suppl):S38-45. PubMed ID: 24527484
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug therapy of overactive bladder--what is coming next?
    Andersson KE
    Korean J Urol; 2015 Oct; 56(10):673-9. PubMed ID: 26495067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of refractory urinary urge incontinence following urogynecological surgery with sacral neuromodulation.
    Starkman JS; Wolter CE; Scarpero HM; Milam DF; Dmochowski RR
    Neurourol Urodyn; 2007; 26(1):29-35; discussion 36. PubMed ID: 17083097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commentary on: Anticholinergic therapy vs onabotulinumtoxinA for urgency urinary incontinence.
    Kobashi KC; Patel B
    Urology; 2013 Jul; 82(1):14-5. PubMed ID: 23642706
    [No Abstract]   [Full Text] [Related]  

  • 38. Best treatment for overactive bladder if behavioral treatment and anticholinergics fail. Onabotulinumtoxina.
    Doggweiler R
    J Urol; 2011 Jun; 185(6):2023-4. PubMed ID: 21496846
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of overactive bladder symptoms beyond antimuscarinics: current and future therapies.
    Ellsworth P
    Postgrad Med; 2012 May; 124(3):16-27. PubMed ID: 22691895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re: Which women develop urgency or urgency urinary incontinence following midurethral slings?
    Wein AJ
    J Urol; 2015 May; 193(5):1590. PubMed ID: 25895777
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.